Sign in
12-Month Results of EYP-1901 Vorolanib in a Bioerodible Durasert Insert for nAMD: The DAVIO Trial
Rishi P. Singh, MD
Updates from the Field
2022
Sustained Diabetic Retinopathy Severity Improvement With Intravitreal Aflibercept in DME: Post Hoc Analysis of VISTA and VIVID
Annual Meeting Talks
2019
Endolaserless Vitrectomy with Intravitreal Aflibercept
Dennis M. Marcus, MD
2017
Category: Diabetic Retinopathy